Health
Store-Brand Mucinex Maker to Move Away from Using Cancer-Causing Chemical
- Amneal says it will bring new formula to market in next year
- Company says it tests quality of materials used to make drugs
The drugmaker has contracts with CVS Health Corp., Walmart Inc., Target Corp., and Rite Aid Corp. to produce their store-brand versions of extended-release Mucinex.
Photographer: Christopher Lee/BloombergThis article is for subscribers only.
The maker of store-brand Mucinex sold by CVS, Walmart and others is reformulating its products to move away from an ingredient that is made with a cancer-causing chemical.
Amneal Pharmaceuticals Inc. plans to submit testing data on its new formulation to the US Food and Drug Administration by the end of the year, the company said in a statement. The company expects to bring the products to market before August 2025.